The Democratic Republic of the Congo has received 16,250 doses of the Ervebo vaccine as the country battles the fastest Ebola outbreak in history, according to the nation’s health minister. The shipment touched down late Friday at N’djili International Airport in Kinshasa, marking the initial arrival of a pledged 70,000 doses designed to curb transmission rates that United Nations officials describe as exponential.
Arrival of Ervebo Doses in Kinshasa
The initial batch of 16,250 doses arrived late Friday evening. These supplies form the first wave of a 70,000-dose commitment announced by the WHO and its partners. Additional shipments are scheduled to arrive early next week to bolster distribution efforts in affected regions, according to reports from the Associated Press.
The outbreak, which health officials believe began weeks before its official mid-May declaration, has recorded 2,516 deaths out of 5,290 confirmed cases, according to data cited by the Associated Press. The Africa Centres for Disease Control and Prevention warns that transmission has not yet peaked and could ultimately reach three times its current known rate.
Targeting the Rare Bundibugyo Strain
While the Ervebo vaccine is approved and licensed to combat the Zaire strain of the virus, the current outbreak in the Democratic Republic of the Congo is driven by the rare Bundibugyo strain. According to the World Health Organization, there is currently no approved vaccine or specific treatment for the Bundibugyo variant.
Despite this mismatch, early data from animal trials indicate that the Ervebo vaccine may still offer some protection against the strain, according to WHO statements. To evaluate this in humans, 20,000 doses of the 70,000-dose allocation are designated for a late-stage clinical trial to measure the vaccine’s effect against the Bundibugyo virus, the WHO announced. The remaining doses will be prioritized for front-line and health workers.
Logistical Challenges in Eastern Congo
Containment efforts continue to face severe hurdles on the ground.
Health Minister Samuel Roger Kamba noted to reporters that Ervebo has a proven track record from past applications, including a large-scale rollout during the 2018 to 2020 outbreak. However, diagnosing the current outbreak remains complicated because symptoms overlap with other illnesses like malaria, according to Associated Press reporting.
Related reading